Canada House Wellness Group wholly-owned subsidiary, Abba Medix, has secured its amended sales license from Health Canada which allows for the sale of its own cannabis directly to patients and consumers.
According to them, With this amendment, Abba plans to sell cannabis, including its own Abba Medix brand, in dried flower format, directly to registered medical patients and authorized provincial/territorial distributors and retailers across Canada. Abba can start legally selling its own branded dry flower on September 18, 2019, after its 60-day Notice of Intent to Sell expires.
Abba’s 22,000 sq. ft. indoor production facility in Pickering, Ontario, has dried flower packaged and ready for sale.
“With our sales license amendment, Abba is ready to take the next step as a Licensed Producer,” said Michael Orrbrooke, Chief Revenue Office, Canada House and President, Abba Medix.
"Abba will continue to ramp up production towards its goal of between 2,000 and 3,000 kg of dried flower on an annualized basis at its Pickering, Ontario facility. It is now in full perpetual grow with regular harvests every three weeks."
“We are thrilled to have achieved this important milestone,” said Chris Churchill-Smith, CEO, Canada House. “Selling our own cannabis to patients and consumers and continuing to pursue further license amendments for oils and other product formats is a key inflection point for us.”